Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial

These results support the integration of LBx-CGP for implementing the efficacy and for optimizing the use of anti-EGFR therapies in RAS/BRAF WT mCRC.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-03-18
DOI
https://doi.org/10.1016/j.esmoop.2025.104511
Citations
11
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
11.50

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial

A. Avallone, Giuseppe Curigliano, Stefania Napolitano, Roberto Bordonaro et al.
11 citations
ESMO Open
Colorectal Cancer Treatments and Studies
11.50
article

Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial

A. Avallone, Giuseppe Curigliano, Stefania Napolitano, Roberto Bordonaro, Saverio Cinieri, G. Martini, A. Lucenti, Gerardo Rosati, C Nisi, Salvatore Pisconti, Rossana Berardi, Emiliano Tamburini, Nicola Fazio, Eleonora Cioli, M. Di Maio, Paola Parente, Simona Vallarelli, Mario Scartozzi, Alessia Russo, I. Toma, A. Febbraro, Alfonso De Stefano, Fortunato Ciardiello, G. Paoletti, E. Martinelli, Evaristo Maiello, Teresa Troiani, Giampaolo Tortora, A. Zaniboni, Sara Lonardi, T. Latiano, N. Normanno, Luca Boscolo Bielo, D. Ciardiello, Donatella Iacono, O. Brunetti, Claudio Lotesoriere, Filippo Pietrantonio, Chiara Cremolini, Maria Giulia Zampino, Pierosandro Tagliaferri, F. De Vita
article en
11 citations

Abstract

These results support the integration of LBx-CGP for implementing the efficacy and for optimizing the use of anti-EGFR therapies in RAS/BRAF WT mCRC.

ESMO OpenVol. 10(4)
Università Cattolica del Sacro Cuore (IT), University of Pisa (IT), Marche Polytechnic University (IT), University of Campania "Luigi Vanvitelli" (IT), Casa Sollievo della Sofferenza (IT), Villa Maria Hospital (UG), Agostino Gemelli University Polyclinic (IT), Magna Graecia University (IT), Azienda Ospedaliera San Camillo-Forlanini (IT), Ospedale di Cattinara (IT), Fondazione Ricerca Molinette (IT), University of Ragusa (IT), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Ospedale A. Perrino (IT), Ospedale Garibaldi (IT), Istituto Oncologico Veneto (IT), Azienda Ospedaliera S.Giuseppe Moscati (IT), Azienda Ospedaliero-Universitaria Cagliari (IT), Istituto Tumori Bari (IT), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Fondazione Poliambulanza Istituto Ospedaliero (IT), University of the Sacred Heart (JP), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Gastroenterology Hospital "Saverio de Bellis" (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), University of Turin (IT), European Institute of Oncology (IT)
Novartis
Good health and well-being
Openalex Percentile: Top 1%
Colorectal Cancer Treatments and Studies
11.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.